For research use only
| Cat No. | ABC-TC3304 |
| Product Type | Mouse Primary Cells |
| Cell Type | Neuron |
| Species | CD-1 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
CD-1 Mouse Neurons (Substantia Nigra) provide a reliable in vitro model for studying dopaminergic neuron function and Parkinson’s disease mechanisms.
CD-1 Mouse Neurons Substantia Nigra are primary dopaminergic neurons isolated from the substantia nigra of pathogen-free neonatal CD-1 mouse brains by enzymatic digestion and gentle mechanical dissociation, preserving high viability and native morphology. These neurons display varied sizes and shapes typical of substantia nigra cells involved in motor control and reward pathways. They express key markers such as tyrosine hydroxylase (TH), NeuN, and DAT. They maintain functional electrophysiological properties and are suitable for Parkinson’s disease modeling, neurodegeneration, and motor function studies. To ensure the quality of these primary cells, repeated freeze-thawcycles are not recommended due to the fragile nature of these cells. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | CD-1 Mouse Neurons Substantia Nigra, Mouse Substantia Nigra Neurons, Substantia Nigra Neurons, Dopaminergic Neurons, SNNs, CD-1 SNNs |
| Species | CD-1 Mouse |
| Cat.No | ABC-TC3304 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Neuron |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
These substantia nigra neurons are ideal for in vitro models studying Parkinson’s disease, dopaminergic signaling, and neurotoxicity assays. They support electrophysiological studies, neuropharmacological testing, and drug discovery focused on movement disorders and neurodegeneration. Additionally, they enable investigation of cellular responses to oxidative stress, neuroinflammation, and mitochondrial dysfunction, providing a comprehensive platform for mechanistic studies, therapeutic screening, and CD-1 mouse brainstem function analysis .
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).